A medical worker prepares a dose of AstraZeneca's COVID-19 vaccine at the Neurological and Functional Rehabilitation Centre of the CHU hospital, amid the spread of the coronavirus disease , in Fraiture, Belgium February 12, 2021. REUTERS/Yves HermanREUTERS: The University of Oxford has launched a trial to test the safety and immune response of its COVID-19 vaccine in children for the first time, it said on Saturday .
The trial will determine whether the Oxford-AstraZeneca vaccine is effective on children and teenagers between the ages of 6 and 17, according to an emailed statement from the university.